Why is Diaceutics Plc ?
1
Poor Management Efficiency with a low ROE of 0.95%
- The company has been able to generate a Return on Equity (avg) of 0.95% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate -199.82% of over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
- RAW MATERIAL COST(Y) Grown by 8.49% (YoY)
- CASH AND EQV(HY) Lowest at GBP 12.74 MM
- DEBT-EQUITY RATIO (HY) Highest at -29.31 %
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 16.31%, its profits have risen by 46.7%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Diaceutics Plc for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Diaceutics Plc
16.31%
0.19
30.08%
FTSE 100
15.94%
1.23
12.99%
Quality key factors
Factor
Value
Sales Growth (5y)
19.07%
EBIT Growth (5y)
-199.82%
EBIT to Interest (avg)
-1.06
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.53
Tax Ratio
10.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.74%
ROE (avg)
0.95%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.76
EV to EBIT
-58.26
EV to EBITDA
45.91
EV to Capital Employed
4.79
EV to Sales
3.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.22%
ROE (Latest)
-4.08%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Diaceutics Plc
Pre-Tax Profit
At GBP 1.36 MM has Grown at 358.29%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (GBP MM)
Net Profit
At GBP 0.88 MM has Grown at 437.55%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (GBP MM)
Net Sales
Highest at GBP 19.84 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (GBP MM)
Net Sales
At GBP 19.84 MM has Grown at 44.01%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (GBP MM)
Operating Profit
Highest at GBP 3.47 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (GBP MM)
Here's what is not working for Diaceutics Plc
Cash and Eqv
Lowest at GBP 12.74 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -29.31 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 8.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






